471 POSTER Plasma pharmacokinetics of CP-4055 in patients with acute myeloid leukaemia at the recommended phase II dose
S. Hagen, S.M. O'Brien, T.F. Jacobsen, H.M. Kantarjian, M.L. Sandvold, F. GilesVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72405-4
File:
PDF, 78 KB
english, 2008